Skip to main content
. 2014 Oct 1;24(8):435–441. doi: 10.1089/cap.2013.0134

FIG. 2.

FIG. 2.

Placebo-adjusted least squares (LS) mean (95% CI) change from baseline in Conners' Parent Rating Scale–Revised: Short Form (CPRS–R:S) subscale scores at visit 10, last observation carried forward (LOCF): (A) oppositional; (B) cognitive problems/inattention; (C) hyperactivity; and (D) attention-deficit/hyperactivity disorder (ADHD) index. *p<0.001; †p<0.01. GXR, guanfacine extended release. LS means and p values are based on type III sum of squares from an analysis of covariance (ANCOVA) model for the change from baseline, with treatment group as a fixed effect and baseline value as a covariate.